APA
Dinges W., Girard P., Podzamczer D., Brockmeyer N. H., García F., Harrer T., Lelievre J., Frank I., Colin De Verdière N., Yeni G., Ortega Gonzalez E., Rubio R., Clotet Sala B., DeJesus E., Pérez-Elias M. J., Launay O., Pialoux G., Slim J., Weiss L., Bouchaud O., Felizarta F., Meurer A., Raffi F., Esser S., Katlama C., Koletar S. L., Mounzer K., Swindells S., Baxter J. D., Schneider S., Chas J., Molina J., Koutsoukos M., Collard A., Bourguignon P. & Roman F. (20160630). The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled Trial. : Medicine.
Chicago
Dinges Warren, Girard Pierre-Marie, Podzamczer Daniel, Brockmeyer Norbert H, García Felipe, Harrer Thomas, Lelievre Jean-Daniel, Frank Ian, Colin De Verdière Nathalie, Yeni Guy-Patrick, Ortega Gonzalez Enrique, Rubio Rafael, Clotet Sala Bonaventura, DeJesus Edwin, Pérez-Elias Maria Jesus, Launay Odile, Pialoux Gilles, Slim Jihad, Weiss Laurence, Bouchaud Olivier, Felizarta Franco, Meurer Anja, Raffi François, Esser Stefan, Katlama Christine, Koletar Susan L, Mounzer Karam, Swindells Susan, Baxter John D, Schneider Stefan, Chas Julie, Molina Jean-Michel, Koutsoukos Marguerite, Collard Alix, Bourguignon Patricia and Roman François. 20160630. The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled Trial. : Medicine.
Harvard
Dinges W., Girard P., Podzamczer D., Brockmeyer N. H., García F., Harrer T., Lelievre J., Frank I., Colin De Verdière N., Yeni G., Ortega Gonzalez E., Rubio R., Clotet Sala B., DeJesus E., Pérez-Elias M. J., Launay O., Pialoux G., Slim J., Weiss L., Bouchaud O., Felizarta F., Meurer A., Raffi F., Esser S., Katlama C., Koletar S. L., Mounzer K., Swindells S., Baxter J. D., Schneider S., Chas J., Molina J., Koutsoukos M., Collard A., Bourguignon P. and Roman F. (20160630). The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled Trial. : Medicine.
MLA
Dinges Warren, Girard Pierre-Marie, Podzamczer Daniel, Brockmeyer Norbert H, García Felipe, Harrer Thomas, Lelievre Jean-Daniel, Frank Ian, Colin De Verdière Nathalie, Yeni Guy-Patrick, Ortega Gonzalez Enrique, Rubio Rafael, Clotet Sala Bonaventura, DeJesus Edwin, Pérez-Elias Maria Jesus, Launay Odile, Pialoux Gilles, Slim Jihad, Weiss Laurence, Bouchaud Olivier, Felizarta Franco, Meurer Anja, Raffi François, Esser Stefan, Katlama Christine, Koletar Susan L, Mounzer Karam, Swindells Susan, Baxter John D, Schneider Stefan, Chas Julie, Molina Jean-Michel, Koutsoukos Marguerite, Collard Alix, Bourguignon Patricia and Roman François. The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled Trial. : Medicine. 20160630.